Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Goodwill (2016 - 2022)

Historic Goodwill for Aytu Biopharma (AYTU) over the last 7 years, with Q1 2022 value amounting to $8.6 million.

  • Aytu Biopharma's Goodwill fell 8687.44% to $8.6 million in Q1 2022 from the same period last year, while for Mar 2022 it was $8.6 million, marking a year-over-year decrease of 8687.44%. This contributed to the annual value of $65.8 million for FY2021, which is 13425.42% up from last year.
  • Latest data reveals that Aytu Biopharma reported Goodwill of $8.6 million as of Q1 2022, which was down 8687.44% from $46.3 million recorded in Q4 2021.
  • Aytu Biopharma's 5-year Goodwill high stood at $65.8 million for Q1 2021, and its period low was $8.6 million during Q1 2022.
  • Its 4-year average for Goodwill is $37.0 million, with a median of $28.1 million in 2020.
  • In the last 5 years, Aytu Biopharma's Goodwill soared by 13425.42% in 2021 and then tumbled by 8687.44% in 2022.
  • Quarter analysis of 4 years shows Aytu Biopharma's Goodwill stood at $15.4 million in 2019, then surged by 82.56% to $28.1 million in 2020, then skyrocketed by 65.0% to $46.3 million in 2021, then tumbled by 81.37% to $8.6 million in 2022.
  • Its Goodwill stands at $8.6 million for Q1 2022, versus $46.3 million for Q4 2021 and $46.3 million for Q3 2021.